Paul Francis Dellaripa, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Diseases, Interstitial | 35 | 2024 | 808 | 4.920 |
Why?
|
Arthritis, Rheumatoid | 29 | 2024 | 3712 | 2.220 |
Why?
|
Scleroderma, Systemic | 5 | 2023 | 323 | 1.030 |
Why?
|
Connective Tissue Diseases | 5 | 2019 | 264 | 0.980 |
Why?
|
Idiopathic Pulmonary Fibrosis | 8 | 2022 | 451 | 0.820 |
Why?
|
Lung Diseases | 6 | 2019 | 1886 | 0.790 |
Why?
|
Eosinophilic Granuloma | 2 | 2017 | 27 | 0.760 |
Why?
|
Autoimmunity | 2 | 2018 | 1349 | 0.710 |
Why?
|
Rheumatic Diseases | 2 | 2017 | 592 | 0.700 |
Why?
|
Rheumatology | 2 | 2022 | 576 | 0.600 |
Why?
|
Lung | 13 | 2023 | 9856 | 0.590 |
Why?
|
Respiratory Sounds | 3 | 2017 | 696 | 0.570 |
Why?
|
Polyarteritis Nodosa | 2 | 2014 | 66 | 0.570 |
Why?
|
Infarction | 2 | 2014 | 244 | 0.530 |
Why?
|
Myositis | 1 | 2018 | 251 | 0.510 |
Why?
|
Immunologic Factors | 2 | 2018 | 1580 | 0.470 |
Why?
|
Respiratory Function Tests | 9 | 2021 | 1616 | 0.420 |
Why?
|
Patient Care | 2 | 2022 | 640 | 0.410 |
Why?
|
Granuloma | 1 | 2013 | 319 | 0.380 |
Why?
|
Abdominal Pain | 2 | 2014 | 1063 | 0.370 |
Why?
|
Antirheumatic Agents | 7 | 2023 | 1339 | 0.370 |
Why?
|
Disease Management | 1 | 2018 | 2459 | 0.310 |
Why?
|
Sarcoidosis | 1 | 2013 | 506 | 0.300 |
Why?
|
Matrix Metalloproteinase 7 | 3 | 2016 | 58 | 0.300 |
Why?
|
Eye Diseases | 1 | 2013 | 669 | 0.300 |
Why?
|
Autoantibodies | 5 | 2022 | 2035 | 0.280 |
Why?
|
Myeloblastin | 2 | 2017 | 101 | 0.270 |
Why?
|
Pleurisy | 3 | 2013 | 53 | 0.270 |
Why?
|
Methotrexate | 4 | 2020 | 1727 | 0.260 |
Why?
|
Skin Diseases | 1 | 2013 | 1065 | 0.240 |
Why?
|
alpha 1-Antitrypsin | 2 | 2017 | 164 | 0.230 |
Why?
|
Immunoglobulin A | 2 | 2019 | 992 | 0.210 |
Why?
|
Nervous System Diseases | 1 | 2013 | 1622 | 0.210 |
Why?
|
Leadership | 1 | 2012 | 1357 | 0.210 |
Why?
|
Lung Transplantation | 2 | 2023 | 1153 | 0.210 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 2 | 2015 | 288 | 0.200 |
Why?
|
Kidney | 2 | 2014 | 7186 | 0.200 |
Why?
|
Humans | 72 | 2024 | 744343 | 0.190 |
Why?
|
Cardiomyopathies | 1 | 2013 | 1912 | 0.190 |
Why?
|
Erythema Induratum | 1 | 2000 | 3 | 0.190 |
Why?
|
Panniculitis, Nodular Nonsuppurative | 1 | 2000 | 7 | 0.190 |
Why?
|
Bronchiectasis | 1 | 2022 | 128 | 0.190 |
Why?
|
Hypertension, Pulmonary | 2 | 2023 | 1537 | 0.190 |
Why?
|
Lipoxygenase Inhibitors | 1 | 2000 | 94 | 0.180 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 2 | 2016 | 49 | 0.180 |
Why?
|
Leukotriene Antagonists | 1 | 2000 | 127 | 0.180 |
Why?
|
Glucocorticoids | 4 | 2019 | 2107 | 0.180 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2019 | 2282 | 0.180 |
Why?
|
Emphysema | 1 | 2022 | 247 | 0.170 |
Why?
|
Polymyositis | 2 | 2018 | 75 | 0.170 |
Why?
|
Rheumatoid Factor | 1 | 2019 | 188 | 0.170 |
Why?
|
Hydroxyurea | 1 | 2000 | 290 | 0.170 |
Why?
|
Acetates | 1 | 2000 | 311 | 0.170 |
Why?
|
Macrophage Migration-Inhibitory Factors | 1 | 2018 | 108 | 0.160 |
Why?
|
Dermatomyositis | 2 | 2019 | 224 | 0.160 |
Why?
|
Giant Cell Arteritis | 2 | 2003 | 292 | 0.160 |
Why?
|
Dyspnea | 3 | 2023 | 1303 | 0.160 |
Why?
|
Intramolecular Oxidoreductases | 1 | 2018 | 109 | 0.160 |
Why?
|
Diagnosis, Differential | 9 | 2017 | 12959 | 0.150 |
Why?
|
Microscopic Polyangiitis | 1 | 2017 | 45 | 0.150 |
Why?
|
Cough | 2 | 2017 | 555 | 0.150 |
Why?
|
Attitude | 1 | 2022 | 776 | 0.150 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2017 | 65 | 0.140 |
Why?
|
Hot Temperature | 1 | 2022 | 1354 | 0.140 |
Why?
|
Blood Sedimentation | 2 | 2014 | 231 | 0.140 |
Why?
|
Middle Aged | 35 | 2023 | 213383 | 0.140 |
Why?
|
Patients | 1 | 2022 | 900 | 0.140 |
Why?
|
Male | 42 | 2023 | 350118 | 0.130 |
Why?
|
Prednisone | 2 | 2017 | 1574 | 0.130 |
Why?
|
Anti-Asthmatic Agents | 1 | 2000 | 536 | 0.130 |
Why?
|
Peroxidase | 2 | 2017 | 611 | 0.130 |
Why?
|
Quinolines | 1 | 2000 | 732 | 0.130 |
Why?
|
Exercise Tolerance | 1 | 2020 | 770 | 0.130 |
Why?
|
Osteopontin | 1 | 2016 | 296 | 0.130 |
Why?
|
Autoimmune Diseases | 2 | 2022 | 2133 | 0.130 |
Why?
|
Systemic Vasculitis | 1 | 2015 | 37 | 0.130 |
Why?
|
Blood Proteins | 1 | 2020 | 1124 | 0.120 |
Why?
|
Pyridones | 1 | 2019 | 712 | 0.120 |
Why?
|
Female | 42 | 2023 | 380194 | 0.120 |
Why?
|
Asthma | 4 | 2017 | 6011 | 0.120 |
Why?
|
Immunoglobulin E | 2 | 2017 | 1463 | 0.120 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2020 | 581 | 0.120 |
Why?
|
Immunosuppressive Agents | 2 | 2020 | 4149 | 0.120 |
Why?
|
Pulmonary Fibrosis | 1 | 2018 | 530 | 0.120 |
Why?
|
Antibodies, Monoclonal | 3 | 2013 | 9274 | 0.120 |
Why?
|
Pleural Diseases | 1 | 2015 | 139 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 10 | 2023 | 20129 | 0.120 |
Why?
|
Chemokine CXCL10 | 1 | 2015 | 304 | 0.120 |
Why?
|
Physicians | 1 | 2012 | 4567 | 0.110 |
Why?
|
Registries | 3 | 2020 | 8089 | 0.110 |
Why?
|
Citrulline | 1 | 2013 | 105 | 0.110 |
Why?
|
Semaphorins | 1 | 2013 | 101 | 0.110 |
Why?
|
Adult | 27 | 2023 | 214055 | 0.110 |
Why?
|
Epithelioid Cells | 1 | 2013 | 71 | 0.110 |
Why?
|
Autoantigens | 2 | 2017 | 892 | 0.110 |
Why?
|
Risk Factors | 12 | 2022 | 72290 | 0.110 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2014 | 314 | 0.110 |
Why?
|
Congresses as Topic | 2 | 2014 | 764 | 0.110 |
Why?
|
Panniculitis | 1 | 2012 | 44 | 0.100 |
Why?
|
Subcutaneous Tissue | 1 | 2012 | 135 | 0.100 |
Why?
|
Internship and Residency | 1 | 2012 | 5788 | 0.100 |
Why?
|
Treatment Failure | 1 | 2017 | 2618 | 0.100 |
Why?
|
Promoter Regions, Genetic | 2 | 2022 | 5867 | 0.100 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2013 | 434 | 0.090 |
Why?
|
Heart Block | 1 | 2012 | 410 | 0.090 |
Why?
|
Severity of Illness Index | 5 | 2023 | 15540 | 0.090 |
Why?
|
Vital Capacity | 2 | 2023 | 925 | 0.090 |
Why?
|
Lymphoma, T-Cell | 1 | 2012 | 299 | 0.090 |
Why?
|
Alleles | 4 | 2018 | 6933 | 0.090 |
Why?
|
Case-Control Studies | 8 | 2022 | 21746 | 0.090 |
Why?
|
Aged | 22 | 2023 | 163280 | 0.090 |
Why?
|
Ischemia | 1 | 1998 | 1907 | 0.090 |
Why?
|
Forced Expiratory Volume | 1 | 2014 | 1743 | 0.090 |
Why?
|
Disease Progression | 3 | 2022 | 13284 | 0.080 |
Why?
|
Pneumonia | 1 | 2020 | 2133 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3870 | 0.080 |
Why?
|
Radiography | 3 | 2014 | 7023 | 0.080 |
Why?
|
Edema | 1 | 2012 | 789 | 0.080 |
Why?
|
Amino Acyl-tRNA Synthetases | 1 | 2009 | 93 | 0.080 |
Why?
|
Organ Specificity | 1 | 2013 | 2008 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 6 | 2018 | 17446 | 0.080 |
Why?
|
Reproducibility of Results | 4 | 2023 | 19905 | 0.070 |
Why?
|
Double-Blind Method | 4 | 2022 | 12026 | 0.070 |
Why?
|
Primary Prevention | 1 | 2014 | 1167 | 0.070 |
Why?
|
Health Behavior | 1 | 2018 | 2636 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2012 | 2373 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1990 | 0.060 |
Why?
|
Consensus | 1 | 2013 | 2959 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2013 | 2046 | 0.060 |
Why?
|
Uridine Triphosphate | 1 | 2023 | 26 | 0.060 |
Why?
|
Hypertension | 2 | 2014 | 8480 | 0.060 |
Why?
|
Gene Frequency | 3 | 2018 | 3588 | 0.060 |
Why?
|
Genetic Loci | 1 | 2012 | 2575 | 0.050 |
Why?
|
Homocysteine | 2 | 1997 | 647 | 0.050 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2006 | 693 | 0.050 |
Why?
|
Immunoglobulin G | 2 | 2011 | 4560 | 0.050 |
Why?
|
Indoles | 2 | 2022 | 1839 | 0.050 |
Why?
|
Mucin-5B | 1 | 2022 | 141 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2012 | 4328 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2018 | 15519 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2023 | 77449 | 0.050 |
Why?
|
Echocardiography | 1 | 2013 | 5102 | 0.050 |
Why?
|
Prognosis | 3 | 2017 | 29063 | 0.050 |
Why?
|
Prospective Studies | 6 | 2023 | 53288 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2022 | 63114 | 0.050 |
Why?
|
Aged, 80 and over | 7 | 2019 | 57776 | 0.050 |
Why?
|
Electrocardiography | 1 | 2013 | 6442 | 0.050 |
Why?
|
Ulnar Nerve Compression Syndromes | 1 | 1999 | 23 | 0.040 |
Why?
|
Life Style | 2 | 2022 | 3835 | 0.040 |
Why?
|
Sulfides | 1 | 2000 | 165 | 0.040 |
Why?
|
Genotype | 4 | 2018 | 12951 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2017 | 10180 | 0.040 |
Why?
|
Fever of Unknown Origin | 1 | 1999 | 93 | 0.040 |
Why?
|
Patient Care Team | 1 | 2010 | 2531 | 0.040 |
Why?
|
Ireland | 1 | 2019 | 161 | 0.040 |
Why?
|
Haplotypes | 2 | 2017 | 2779 | 0.040 |
Why?
|
Cyclopropanes | 1 | 2000 | 416 | 0.040 |
Why?
|
ROC Curve | 2 | 2016 | 3527 | 0.040 |
Why?
|
Young Adult | 4 | 2017 | 56430 | 0.040 |
Why?
|
Telomere | 1 | 2024 | 910 | 0.040 |
Why?
|
HLA-DP Antigens | 1 | 2017 | 28 | 0.040 |
Why?
|
Regression Analysis | 2 | 2020 | 6459 | 0.040 |
Why?
|
International Classification of Diseases | 1 | 2023 | 867 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 4420 | 0.040 |
Why?
|
Sex Factors | 3 | 2020 | 10397 | 0.040 |
Why?
|
Odds Ratio | 2 | 2022 | 9849 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15165 | 0.040 |
Why?
|
Temporal Arteries | 1 | 1998 | 128 | 0.040 |
Why?
|
Idiopathic Interstitial Pneumonias | 1 | 2016 | 19 | 0.040 |
Why?
|
Vascular Resistance | 1 | 2020 | 936 | 0.040 |
Why?
|
Peptides, Cyclic | 1 | 2019 | 400 | 0.040 |
Why?
|
Demography | 1 | 2022 | 1656 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2013 | 9959 | 0.040 |
Why?
|
Sjogren's Syndrome | 1 | 2019 | 233 | 0.040 |
Why?
|
United States | 5 | 2019 | 69872 | 0.040 |
Why?
|
Pleural Effusion | 1 | 1999 | 338 | 0.030 |
Why?
|
Methionine | 2 | 1997 | 590 | 0.030 |
Why?
|
Genetic Variation | 1 | 2011 | 6544 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2018 | 802 | 0.030 |
Why?
|
Respiratory Mechanics | 1 | 2020 | 686 | 0.030 |
Why?
|
Axilla | 1 | 1998 | 595 | 0.030 |
Why?
|
Cystathionine beta-Synthase | 1 | 1995 | 27 | 0.030 |
Why?
|
Placebos | 1 | 2020 | 1676 | 0.030 |
Why?
|
Prevalence | 2 | 2023 | 15226 | 0.030 |
Why?
|
Gene Expression | 2 | 2018 | 7799 | 0.030 |
Why?
|
Syndrome | 2 | 2013 | 3251 | 0.030 |
Why?
|
Age Factors | 3 | 2020 | 18370 | 0.030 |
Why?
|
Societies, Medical | 2 | 2019 | 3743 | 0.030 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2015 | 428 | 0.030 |
Why?
|
Neutrophils | 3 | 2017 | 3719 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2022 | 5535 | 0.030 |
Why?
|
Cohort Studies | 5 | 2016 | 40561 | 0.030 |
Why?
|
Angioplasty, Balloon | 1 | 1998 | 653 | 0.030 |
Why?
|
Biopsy | 2 | 2018 | 6756 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2016 | 14722 | 0.030 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2017 | 220 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2386 | 0.030 |
Why?
|
Mesenteric Artery, Superior | 1 | 2014 | 101 | 0.030 |
Why?
|
Survival Rate | 2 | 2018 | 12788 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2020 | 1869 | 0.030 |
Why?
|
Mixed Connective Tissue Disease | 1 | 2013 | 26 | 0.030 |
Why?
|
Morbidity | 1 | 2018 | 1769 | 0.030 |
Why?
|
Angiography | 1 | 1998 | 1639 | 0.030 |
Why?
|
Exercise Test | 1 | 2020 | 2074 | 0.030 |
Why?
|
Opportunistic Infections | 1 | 2015 | 389 | 0.030 |
Why?
|
Quality of Life | 2 | 2023 | 12804 | 0.030 |
Why?
|
Area Under Curve | 1 | 2015 | 1654 | 0.020 |
Why?
|
Chemokines | 1 | 2015 | 970 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2013 | 905 | 0.020 |
Why?
|
Health Status | 1 | 2003 | 4034 | 0.020 |
Why?
|
Major Histocompatibility Complex | 1 | 2013 | 936 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 40075 | 0.020 |
Why?
|
Massachusetts | 1 | 2022 | 8663 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 1998 | 1855 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3638 | 0.020 |
Why?
|
China | 1 | 2015 | 2248 | 0.020 |
Why?
|
Raynaud Disease | 1 | 2009 | 74 | 0.020 |
Why?
|
Motivation | 1 | 2018 | 1971 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2013 | 1730 | 0.020 |
Why?
|
Receptors, Fc | 1 | 2011 | 541 | 0.020 |
Why?
|
Comorbidity | 1 | 2022 | 10388 | 0.020 |
Why?
|
Databases, Factual | 1 | 2023 | 7729 | 0.020 |
Why?
|
Logistic Models | 1 | 2022 | 13408 | 0.020 |
Why?
|
Monocytes | 1 | 2017 | 2596 | 0.020 |
Why?
|
International Cooperation | 1 | 2013 | 1420 | 0.020 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1999 | 2104 | 0.020 |
Why?
|
Inflammation | 2 | 2020 | 10638 | 0.020 |
Why?
|
Smoking | 1 | 2024 | 8987 | 0.020 |
Why?
|
Incidence | 2 | 2019 | 20947 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2009 | 595 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2017 | 12261 | 0.020 |
Why?
|
Face | 1 | 2012 | 994 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2023 | 4468 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2013 | 2203 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12354 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2699 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2703 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2017 | 4665 | 0.010 |
Why?
|
Graft Rejection | 1 | 2016 | 4397 | 0.010 |
Why?
|
Hand | 1 | 2009 | 884 | 0.010 |
Why?
|
Exercise | 1 | 2020 | 5615 | 0.010 |
Why?
|
Arthritis | 1 | 2009 | 659 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2012 | 1620 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 13989 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10262 | 0.010 |
Why?
|
Algorithms | 1 | 2023 | 13881 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8388 | 0.010 |
Why?
|
Fever | 1 | 2009 | 1616 | 0.010 |
Why?
|
Models, Genetic | 1 | 2011 | 3494 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 21827 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2011 | 2149 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8340 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16365 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39050 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 41006 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18029 | 0.010 |
Why?
|
Chronic Disease | 1 | 2014 | 9146 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11366 | 0.010 |
Why?
|
Antibodies, Antinuclear | 1 | 1999 | 326 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 23338 | 0.010 |
Why?
|
Vision Disorders | 1 | 2003 | 1058 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15076 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6234 | 0.010 |
Why?
|
Vitamin B 12 Deficiency | 1 | 1997 | 116 | 0.010 |
Why?
|
Genomics | 1 | 2011 | 5720 | 0.010 |
Why?
|
Adolescent | 2 | 2013 | 85781 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2003 | 2418 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 1997 | 527 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11524 | 0.010 |
Why?
|
Mice | 1 | 2018 | 81183 | 0.010 |
Why?
|
Fasting | 1 | 1997 | 1593 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 25043 | 0.010 |
Why?
|
Animals | 1 | 2018 | 168757 | 0.000 |
Why?
|